JO2238B1 - منشطات جلوكيناز ايسويندلين 1- اون - Google Patents

منشطات جلوكيناز ايسويندلين 1- اون

Info

Publication number
JO2238B1
JO2238B1 JO2001193A JOP20010193A JO2238B1 JO 2238 B1 JO2238 B1 JO 2238B1 JO 2001193 A JO2001193 A JO 2001193A JO P20010193 A JOP20010193 A JO P20010193A JO 2238 B1 JO2238 B1 JO 2238B1
Authority
JO
Jordan
Prior art keywords
isoindolin
glucokinase activators
glucokinase
activators
diabetes
Prior art date
Application number
JO2001193A
Other languages
English (en)
Inventor
ريتشارد جورتين كيفن
Original Assignee
اف. هوفمان- لاروش أيه جي‏
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by اف. هوفمان- لاروش أيه جي‏ filed Critical اف. هوفمان- لاروش أيه جي‏
Application granted granted Critical
Publication of JO2238B1 publication Critical patent/JO2238B1/ar

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JO2001193A 2000-12-13 2001-12-09 منشطات جلوكيناز ايسويندلين 1- اون JO2238B1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25527300P 2000-12-13 2000-12-13

Publications (1)

Publication Number Publication Date
JO2238B1 true JO2238B1 (ar) 2004-10-07

Family

ID=40418787

Family Applications (1)

Application Number Title Priority Date Filing Date
JO2001193A JO2238B1 (ar) 2000-12-13 2001-12-09 منشطات جلوكيناز ايسويندلين 1- اون

Country Status (4)

Country Link
AR (1) AR035405A1 (ar)
EC (1) ECSP034651A (ar)
GT (1) GT200100247A (ar)
JO (1) JO2238B1 (ar)

Also Published As

Publication number Publication date
GT200100247A (es) 2002-07-31
ECSP034651A (es) 2003-07-25
AR035405A1 (es) 2004-05-26

Similar Documents

Publication Publication Date Title
EG24358A (en) Isoindolin-1-one glucokinase avtivators
MY135222A (en) Substituted phenylacetamides and their use as glucokinase activators
MY180762A (en) Combination therapy comprising glucose reabsorption inhibitors and ppar modulators.
MXPA05008406A (es) Compuestos de amida tri(ciclo)-sustituida.
YU68002A (sh) Modifikovani faktor viii
JO2180B1 (ar) منشطات جلوكوكيناز ترانس اوليفني
AU2002213925A1 (en) Use of glp-1 and flp-2 peptides for treatment of bone disorders
CA2499329A1 (en) Indole-3-carboxamides as glucokinase (gk) activators
WO2001083465A3 (en) Alkynyl phenyl heteroaromatic glucokinase activators
MXPA03003870A (es) Terapia de combinacion que comprende agentes antidiabeticos y anticonvulsionantes.
PT1311504E (pt) Tetrazolil-fenil-acetamidas activadoras da glucoquinase
MXPA02008722A (es) Inhibidores novedosos de aril fructosa-1,6-bisfosfatasa.
SG148034A1 (en) Non-neurotoxic plasminogen activating factors for treating stroke
PT1435991E (pt) Utilização de aplidina para o tratamento de cancro pancreático
NZ525774A (en) Use of SARP-1 for the treatment and/or prevention of scleroderma
WO2002024181A3 (en) The use of melatonin for induction of general anesthesia
JO2238B1 (ar) منشطات جلوكيناز ايسويندلين 1- اون
MXPA04000418A (es) Tratamiento de dolor cronico con 3-heterocicloxi- y -cicloalquiloxi-3-fenilpropanaminas.
GB0212790D0 (en) Medicament for the treatment of diabetes
AU2003249999A8 (en) 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours
WO2001078765A3 (de) Prophylaxe und therapie von diabetes mellitus 1 mit hilfe proteolytischer enzyme
MXPA04003673A (es) Uso de aplidina para el tratamiento de cancer pancreatico.
UA42301A (uk) Засіб "камілаль" для лікування і профілактики проктологічних захворювань
UA32466C2 (uk) Комплексний інфузійний препарат "реосорбілакт"
UA32314A (uk) Спосіб лікування некротичного панкреатиту